From beside to bench and back: How patient-derived organoids and 3D models can improve cancer research and therapy decisions
- In: Pharmaceutical scientists in cancer research: From new drugs to better disease modelling and treatment efficacy on Tuesday, 2 September 2025, 09:00-10:30
- At: Copenhagen (Denmark) (2025)
- Type: Presentation
- By: GIOLITO, Maria Virginia
- Abstract:
Patient-derived organoids and three-dimensional spheroid models have significantly transformed preclinical cancer research by offering exceptional physiological relevance in comparison to traditional two-dimensional cell cultures. This presentation will explore the evolution of these innovative models, detailing their development in laboratory..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 September 2025